{"id":"NCT00382993","sponsor":"GlaxoSmithKline","briefTitle":"A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)","officialTitle":"A Study of Combination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-12","primaryCompletion":"2007-11","completion":"2007-11","firstPosted":"2006-10-02","resultsPosted":"2010-04-20","lastUpdate":"2017-02-02"},"enrollment":169,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Migraine Disorders"],"interventions":[{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Combination Product (sumatriptan succinate/naproxen sodium)","otherNames":[]}],"arms":[{"label":"Combination Product - Placebo","type":"OTHER"},{"label":"Placebo - Combination Product","type":"OTHER"}],"summary":"This is a randomized, double-blind, placebo-controlled, crossover, two-attack, out-patient, early-intervention evaluation of subjects who have migraine with or without aura and who discontinued use of short acting triptan(s) within the past year due to non-response or intolerance. Subjects will treat 2 separate migraine attacks during the mild phase of each attack; one attack will be treated with one tablet of the Combination Product (sumatriptan succinate and naproxen sodium) and the other attack with one tablet of placebo (crossover design). \\[Study 2 of 2\\]","primaryOutcome":{"measure":"Sustained Freedom From Migraine Pain Between 2-24 Hours Post-dose","timeFrame":"2 - 24 Hours Post-Dose","effectByArm":[{"arm":"Placebo","deltaMin":10,"sd":null},{"arm":"Sumatriptan/Naproxen Sodium","deltaMin":41,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":19,"exclusionCount":28},"locations":{"siteCount":28,"countries":["United States"]},"refs":{"pmids":["19486178"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":135},"commonTop":[]}}